Newcelx Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$3.35

-0.26 (-7.08%)

As of Aug 14, 10:22 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,112.9% upside

Low Target $36.99

Average Target $40.57

High Target $64.99

Current Price $3.35

Current
$3.35

Target
$40.57

$36.99 $40.57 avg $64.99

Scenario Analysis

Bear Case

$36.99

1,005.8%

Low target

Base Case

$40.57

+1,112.9%

Avg target

Bull Case

$64.99

+1,842.9%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$28.03

-88.1% from high

52-Week Low

$1.83

+82.8% from low

Target vs 52W High

$40.57

+44.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%